ERBB3 and cervical adenocarcinoma: Whole-exome or targeted sequencing data including the Cancer Genome Atlas (TCGA) revealed that the incidence of HER3 mutations was higher in adenocarcinoma of the uterine cervix than in squamous cell carcinoma [31,56,57].